eVestment Alliance, LLC – Trademark Portfolio
Entity Type: 16
eVestment Alliance, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MARKET LENS. The owner is based in Atlanta, GA.
100 Glenridge Point Parkway, Suite 100
Atlanta, GA 30342
Showing of trademarks Trademarks
Trademark Classifications
eVestment Alliance, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does eVestment Alliance, LLC have?
eVestment Alliance, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 cancelled.
What trademark classes does eVestment Alliance, LLC file in?
eVestment Alliance, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are eVestment Alliance, LLC's most well-known trademarks?
eVestment Alliance, LLC's registered trademark portfolio includes well-known marks such as MARKET LENS. These are among 1 currently registered trademark in the portfolio.
What is eVestment Alliance, LLC's trademark registration success rate?
eVestment Alliance, LLC has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.